Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

Who May Qualify: - Patients with thrombotic left iliac vein compression syndrome who underwent left iliac vein stent implantation Who Should NOT Join This Trial: - Age \< 18 years or age \> 75 years - With history of pelvic surgery, left iliac vein trauma and pelvic radiotherapy - With obvious contraindications for anticoagulation therapy - Allergic to iodine contrast agents in the past - With concomitant diseases that need high-intensity anticoagulation, and the anticoagulation intensity is clearly higher than that of the patients with iliac vein therapy alone - Active bleeding or potential bleeding risk - Pregnant or breastfeeding women - With pelvic tumors causing compression of left iliac vein, - With chronic venous insufficiency of lower extremities caused by K-T syndrome - With malignant tumors and life expectancy \< 1 year - Taking cytochrome P450 3A4(CYP-450 3A4) inhibitors or inducers Always talk to your doctor about whether this trial is right for you.